Export certification for marine biotech products

Introduction

Export certification for marine biotech products refers to the regulatory process through which authorities verify that marine-derived biotechnology products comply with applicable safety, quality, environmental, sanitary and international trade requirements before being exported. These products may include marine enzymes, algae-based pharmaceuticals, bioactive compounds, nutraceuticals, marine microorganisms, genetically modified marine organisms, diagnostic materials and biotechnology-based aquaculture products.

Marine biotechnology has significant commercial potential because marine organisms contain valuable biological compounds used in medicine, agriculture, food processing and industrial manufacturing. However, their export creates regulatory concerns relating to biodiversity conservation, biosafety, product quality, intellectual property and access to marine genetic resources.

Export certification therefore serves as an important mechanism for ensuring that marine biotech products are legally sourced, scientifically assessed and suitable for international markets.

Legal framework governing export certification in India

India regulates marine biotechnology exports through several laws and regulatory institutions.

1. Foreign Trade (Development and Regulation) Act, 1992

This legislation provides the statutory framework for regulating exports and imports. Section 3 empowers the Central Government to issue orders restricting or regulating exports. Exporters must comply with applicable export policies, licensing requirements and notifications issued by the Directorate General of Foreign Trade (DGFT).

2. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources and associated traditional knowledge in India. Marine biological resources may fall within its scope. The Act, as amended in 2023, provides a framework for access, benefit-sharing and regulatory exemptions.

Exporters dealing with marine genetic resources must examine whether approvals, registrations or benefit-sharing obligations apply to their activities. The precise requirements depend on the nature of the resource, the exporter's status and the applicable statutory provisions.

3. Environment (Protection) Act, 1986

The Environment (Protection) Act and the rules framed under it regulate activities involving hazardous microorganisms and genetically engineered organisms. Marine biotechnology products involving genetically modified microorganisms or organisms may require biosafety assessment and approvals under the applicable regulatory framework.

4. Marine Products Export Development Authority Act, 1972

The Marine Products Export Development Authority (MPEDA) promotes the export of marine products and supports quality assurance, processing standards and international market compliance. Its regulatory relevance depends on the product category and applicable export requirements. Not every marine-derived biotechnology product automatically falls within the same certification system as conventional seafood.

Major requirements for export certification

Export certification involves several compliance stages. First, exporters must establish the legal origin of marine biological materials. This includes documenting collection permissions, research access approvals and applicable benefit-sharing obligations.

Second, the product must satisfy relevant safety and quality standards. Depending on its intended use, certification may require:

Microbiological and chemical testing.

Verification of product composition and purity.

Assessment of contamination and toxicity.

Stability and shelf-life testing.

Biosafety evaluation for genetically modified materials.

Manufacturing and quality-control documentation.

Third, exporters must identify the destination country's regulatory requirements. A marine enzyme intended for industrial use may face different requirements from a marine-derived pharmaceutical or food ingredient.

For pharmaceutical products, applicable drug regulatory requirements and destination-country authorisations may be necessary. For food and nutraceutical products, food safety and labelling standards may apply.

International legal framework

The World Trade Organization's Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) is relevant where marine biotech products are subject to measures protecting human, animal or plant health. Such measures should be based on scientific principles and risk assessment.

The Agreement on Technical Barriers to Trade (TBT Agreement) may apply to technical regulations, standards and conformity-assessment procedures that are not covered by the SPS Agreement. Certification requirements should not create unnecessary obstacles to international trade.

The Convention on Biological Diversity (CBD) and the Nagoya Protocol are also important. They establish principles relating to access to genetic resources and fair and equitable sharing of benefits arising from their utilisation, subject to national implementation and applicable scope provisions.

Important judicial and international decisions

1. European Communities – Approval and Marketing of Biotech Products (WTO, 2006)

This dispute concerned delays and restrictions affecting genetically modified agricultural products. The WTO examined regulatory measures under international trade rules. Although it did not concern marine biotechnology exports, it demonstrates the importance of scientific justification and procedural consistency when regulating biotechnology products.

2. Australia – Measures Affecting the Importation of Salmon (WTO, 1998)

This dispute examined Australia's restrictions on imported salmon products under the SPS Agreement. The WTO Appellate Body considered scientific evidence, risk assessment and the relationship between sanitary restrictions and international trade. The decision is relevant by analogy to marine biotech certification where authorities impose health-related testing and safety requirements.

3. India – Quantitative Restrictions on Imports (WTO, 1999)

This dispute concerned India's quantitative restrictions on imports. It illustrates that trade-related regulatory measures must comply with WTO obligations and cannot be justified merely by invoking domestic regulatory objectives without satisfying applicable legal conditions. Its relevance to export certification is indirect.

4. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and polluter-pays principle as important components of Indian environmental law. These principles are relevant to marine biotechnology because activities involving marine organisms may create ecological risks requiring preventive assessment and regulatory supervision.

Challenges in marine biotech export certification

Marine biotech exporters may face difficulties due to inconsistent international standards, expensive laboratory testing, lengthy approval procedures and uncertainty regarding the classification of novel biological products. Another challenge is determining whether a product is regulated as a pharmaceutical, food ingredient, industrial enzyme or biological research material.

There may also be disputes concerning access to marine genetic resources and benefit-sharing obligations. Export certification must therefore consider both commercial compliance and biodiversity protection.

Conclusion

Export certification for marine biotech products is essential for ensuring product safety, environmental responsibility and compliance with international trade requirements. In India, the Foreign Trade Act, Biological Diversity Act, Environment (Protection) Act and relevant sector-specific regulations provide the principal legal framework. WTO agreements and international biodiversity instruments further influence certification standards. Effective certification requires scientific testing, traceable sourcing, transparent approvals and cooperation between regulatory authorities. Although direct judicial decisions specifically addressing marine biotech export certification remain limited, biotechnology, environmental and international trade disputes provide important legal principles for interpreting the regulatory framework.